Search Results - "Murakami, Maryann"
-
1
Determination of 19 Cardiac Troponin I and T Assay 99th Percentile Values from a Common Presumably Healthy Population
Published in Clinical chemistry (Baltimore, Md.) (01-11-2012)“…Between-assay comparability of 99th percentiles for cardiac troponin concentrations has not been assessed systematically in a single population for a large…”
Get full text
Journal Article -
2
Role of Monitoring Changes in Sensitive Cardiac Troponin I Assay Results for Early Diagnosis of Myocardial Infarction and Prediction of Risk of Adverse Events
Published in Clinical chemistry (Baltimore, Md.) (01-05-2009)“…We sought to determine the diagnostic accuracy of the cardiac troponin I (cTnI) VITROS(R) Troponin I-ES assay for early detection of acute myocardial…”
Get full text
Journal Article -
3
Diagnosis of type 1 and type 2 myocardial infarction using a high-sensitivity cardiac troponin I assay with sex-specific 99th percentiles based on the third universal definition of myocardial infarction classification system
Published in Clinical chemistry (Baltimore, Md.) (01-04-2015)“…The frequency and characteristics of myocardial infarction (MI) subtypes per the Third Universal Definition of MI (TUDMI) classification system using…”
Get full text
Journal Article -
4
Use of the Centaur TnI-Ultra Assay for Detection of Myocardial Infarction and Adverse Events in Patients Presenting With Symptoms Suggestive of Acute Coronary Syndrome
Published in Clinical chemistry (Baltimore, Md.) (01-04-2008)“…We determined the diagnostic accuracy of the Advia Centaur TnI-Ultra assay for detecting myocardial infarction (MI) and assessing risk of adverse events in…”
Get full text
Journal Article -
5
Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1
Published in Nature medicine (01-11-2007)“…Anorexia and weight loss are part of the wasting syndrome of late-stage cancer, are a major cause of morbidity and mortality in cancer, and are thought to be…”
Get full text
Journal Article -
6
Diagnostic performance of four point of care cardiac troponin I assays to rule in and rule out acute myocardial infarction
Published in Clinical biochemistry (01-11-2013)“…This study evaluated the diagnostic performance of four point-of-care (POC) cardiac troponin I (cTnI) assays compared to a central laboratory cTnI assay for…”
Get full text
Journal Article -
7
Defining the serum 99th percentile in a normal reference population measured by a high-sensitivity cardiac troponin I assay
Published in Clinical biochemistry (01-08-2010)“…This study determined the serum 99th percentile reference value for cTnI measured using the high sensitivity Erenna® cTnI assay. Serum was obtained from…”
Get full text
Journal Article -
8
Increased Cardiac Troponin I As Measured by a High-Sensitivity Assay Is Associated with High Odds of Cardiovascular Death: The Minnesota Heart Survey
Published in Clinical chemistry (Baltimore, Md.) (01-05-2012)“…We examined several novel biomarkers of different pathophysiologic pathways as predictors of cardiovascular mortality in participants enrolled in the Minnesota…”
Get full text
Journal Article -
9
Cardiac troponin changes to distinguish type 1 and type 2 myocardial infarction and 180-day mortality risk
Published in European heart journal. Acute cardiovascular care (01-12-2014)“…Aims: To determine the ability of serial cardiac troponin (cTnI) changes (delta) to distinguish type 1 and type 2 myocardial infarction (MI) (excluding all…”
Get full text
Journal Article -
10
GENDER DIFFERENCES IN MORTALITY AMONG PATIENTS WITH SUPPLY-DEMAND TYPE 2 MYOCARDIAL INFARCTION, TYPE 1 MYOCARDIAL INFARCTION AND NON-MI CARDIAC TROPONIN I INCREASES
Published in Journal of the American College of Cardiology (17-03-2015)“…In-hospital mortality and post-discharge mortality in men was 5% and 9% in T1MI, 9% and 17% in T2MI, 12% and 16% in non-MI cTnI increases, and 2% and 5% in no…”
Get full text
Journal Article -
11
Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease
Published in Circulation (New York, N.Y.) (03-12-2002)“…This study determined the prevalence of increased cardiac troponin I (cTnI) and T (cTnT) in end-stage renal disease (ESRD) patients and whether an increased…”
Get full text
Journal Article -
12
Analytical Characteristics of Commercial Cardiac Troponin I and T Immunoassays in Serum from Rats, Dogs, and Monkeys with Induced Acute Myocardial Injury
Published in Clinical chemistry (Baltimore, Md.) (01-12-2008)“…Information is needed regarding analytical characteristics of cardiac troponin (cTn) assays used in preclinical studies. We measured cTnI and cTnT in serum…”
Get full text
Journal Article -
13
Assessment of the Multiple-Biomarker Approach for Diagnosis of Myocardial Infarction in Patients Presenting with Symptoms Suggestive of Acute Coronary Syndrome
Published in Clinical chemistry (Baltimore, Md.) (01-01-2009)“…Cardiac troponin is the preferred biomarker for detecting acute myocardial injury and infarction (MI). We studied whether multiple biomarkers of numerous…”
Get full text
Journal Article -
14
Immunodetection of Glycosylated NT-proBNP Circulating in Human Blood
Published in Clinical chemistry (Baltimore, Md.) (01-05-2008)“…Brain natriuretic peptide (BNP) or NT-proBNP (N-terminal fragment of BNP precursor) measurements are recommended as aids in diagnosis and prognosis of patients…”
Get full text
Journal Article -
15
Multiple Biomarker Use for Detection of Adverse Events in Patients Presenting with Symptoms Suggestive of Acute Coronary Syndrome
Published in Clinical chemistry (Baltimore, Md.) (01-05-2007)“…We investigated multiple biomarkers of various pathophysiologic pathways to determine their relationships with adverse outcomes in patients presenting with…”
Get full text
Journal Article -
16
Electronic medical record-based performance improvement project to document and reduce excessive cardiac troponin testing
Published in Clinical chemistry (Baltimore, Md.) (01-03-2015)“…We assessed the utilization rationale behind provider ordering of cardiac troponin I (cTnI) testing for the diagnosis of myocardial infarction after…”
Get full text
Journal Article -
17
Performance characteristics of the ARCHITECT Galectin-3 assay
Published in Clinical biochemistry (01-01-2013)“…Galectin-3 is an emerging biomarker that is commonly increased in patients with heart failure and/or patients at risk for cardiovascular disease. We evaluated…”
Get full text
Journal Article -
18
Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-Ultra assay
Published in Clinical biochemistry (01-07-2012)“…We determined diagnostic accuracy and risk stratification using delta changes for the cardiac troponin I (cTnI) Centaur Ultra assay for ruling out acute…”
Get full text
Journal Article -
19
Cardiac troponin testing is overused after the rule-in or rule-out of myocardial infarction
Published in Clinical chemistry (Baltimore, Md.) (01-02-2015)“…After receiving institutional review board approval, we retrospectively reviewed electronic health/ medical records in 100 consecutive patients who had serial…”
Get full text
Journal Article -
20